DYRKi is a novel nontoxic and selective DYRK1 inhibitor. References: Peromaa-Haavisto P, Tuomilehto H, Kossi J, Virtanen J, Luostarinen M, Pihlajamaki J, Kakela P, Victorzon M. Obstructive sleep apnea: the effect of bariatric surgery after 12 months. A prospective multicenter trial. Sleep Med. 2017 Jan 12. pii: S1389-9457(17)30004-7. doi: 10.1016/j.sleep.2016.12.017. [Epub ahead of print] PubMed PMID: 28549834.

纯度：≥98%

CAS：1640364-04-0